Senseonics’ (SENS) “Hold” Rating Reiterated at Stifel Nicolaus

Stifel Nicolaus reiterated their hold rating on shares of Senseonics (NASDAQ:SENS) in a research report sent to investors on Tuesday morning,Benzinga reports. The firm currently has a $10.00 price objective on the stock, up from their previous price objective of $9.00.

SENS has been the topic of several other reports. HC Wainwright reiterated a “buy” rating and set a $14.00 target price on shares of Senseonics in a research report on Tuesday. TD Cowen reaffirmed a “buy” rating and set a $15.00 price target on shares of Senseonics in a report on Tuesday, October 27th. Wall Street Zen upgraded shares of Senseonics from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Weiss Ratings raised Senseonics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, November 4th. Finally, Barclays assumed coverage on shares of Senseonics in a report on Wednesday, October 7th. They set an “equal weight” rating and a $10.00 price objective for the company. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Senseonics currently has a consensus rating of “Hold” and an average price target of $14.40.

Senseonics Trading Down 3.6%

NASDAQ SENS opened at $10.04 on Tuesday. Senseonics has a 52 week low of $4.79 and a 52 week high of $13.98. The company has a quick ratio of 6.40, a current ratio of 5.92 and a debt-to-equity ratio of 0.70. The company has a 50-day moving average price of $9.16 and a 200-day moving average price of $7.31.

Senseonics (NASDAQ:SENS) last issued its quarterly earnings results on Monday, November 9th. The company reported ($0.50) earnings per share for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics had a negative return on equity of 186.11% and a negative net margin of 204.01%. The business had revenue of $19.56 million for the quarter. As a group, analysts predict that Senseonics will post -2.30 EPS for the current year.

Insider Transactions at Senseonics

In other Senseonics news, Director Douglas Roeder bought 13,953 shares of the company’s stock in a transaction on Wednesday, August 19th. The stock was acquired at an average price of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the transaction, the director directly owned 171,191 shares of the company’s stock, valued at approximately $1,537,295.18. This represents a 8.87% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 4.70% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Senseonics

Several hedge funds and other institutional investors have recently modified their holdings of the business. State of Wyoming lifted its stake in shares of Senseonics by 27.2% during the 3rd quarter. State of Wyoming now owns 14,940 shares of the company’s stock worth $152,000 after acquiring an additional 3,199 shares during the last quarter. Integrated Wealth Concepts LLC bought a new stake in shares of Senseonics during the second quarter worth $36,000. Kestra Advisory Services LLC purchased a new stake in shares of Senseonics during the first quarter valued at $68,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Senseonics during the second quarter valued at $65,000. Finally, StoneX Group Inc. purchased a new stake in shares of Senseonics during the third quarter valued at $128,000. 12.36% of the stock is currently owned by hedge funds and other institutional investors.

More Senseonics News

Investors following SENS have been watching these news items:

• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and $14 price target. It also raised its FY2026 estimate and improved its forecasts for FY2028–FY2030, suggesting a more favorable longer-term earnings trajectory. HC Wainwright rating reaffirmed
• Positive Sentiment: Other analyst headlines cite strong price-appreciation outlooks from Mizuho and Barclays, and a TD Cowen price-target increase. Mizuho forecast Barclays forecast TD Cowen target
• Negative Sentiment: HC Wainwright lowered estimates for Q4 2026 and Q1–Q2 2027, and reduced its FY2027 forecast to a loss of $2.13 per share from $2.05. These near-term revisions could temper the positive effect of its Buy rating, although it raised its Q3 2027 estimate.

Senseonics Company Profile

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.